Follow the 쓰리빌리언 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 쓰리빌리언 has published 1 insider filings. Market capitalisation: €153.4bn. The latest transaction was disclosed on 1 April 2026 (Purchase). Among the most active insiders: 국민연금공단. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
쓰리빌리언 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance patient health.